Press releasePRNewswire
Tyra Biosciences
TYRA · NASDAQ
$20.47+$1.13 (+5.84%)TodayMarket closed ·
Prev close $19.34
Latest news
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
- Press releaseGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
- NewsRishabh Mishra
Stock Market Today: S&P 500, Dow and Nasdaq Futures Fall as Brent Hovers Near $107 and FOMC Commences Two-Day Meeting— MSTR, CRWD, BMM in Focus (UPDATED)
- NewsAvi Kapoor
Crude Oil Jumps 3%; Corning Shares Move Lower
- Press releasePRNewswire
Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsVandana Singh
Why Is Tyra Biosciences Stock Sinking Wednesday?
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releasePRNewswire
Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
- Press releasePRNewswire
Tyra Biosciences to Present at the Cantor Global Healthcare Conference
- Press releasePRNewswire
Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026
- Press releasePRNewswire
Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights
- Press releasePRNewswire
TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY
- Press releasePRNewswire
Tyra Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights
- Press releasePRNewswire
Tyra Biosciences to Participate in Upcoming Investor Conferences
- Press releasePRNewswire
Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors
- Press releasePRNewswire
Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights
- Press releasePRNewswire
Tyra Biosciences Announces Poster Presentations at the 2026 ASCO® Genitourinary (GU) Cancers Symposium
- Press releasePRNewswire
Tyra Biosciences to Participate in Upcoming Investor Conferences
- Press releasePRNewswire
Tyra Biosciences Strengthens Leadership Team with Appointments of Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer
- Press releasePRNewswire
Tyra Biosciences Announces Participation at Upcoming Investor Events
- Press releasePRNewswire
Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights
- Press releasePRNewswire
Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia
- Press releasePRNewswire
Tyra Biosciences Announces Participation at Upcoming Investor Events
- Press releasePRNewswire
Tyra Biosciences Reports Second Quarter 2025 Financial Results and Highlights
- Press releasePRNewswire
Tyra Biosciences Announces Fireside Chat on Achondroplasia and Growth Disorders at UBS Biotech Management Live Call Series
- NewsAvi Kapoor
Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- NewsAvi Kapoor
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsAvi Kapoor
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.